We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIFU
2101
AIFU Inc
AIFU
$201M
| $269K | ﹤0.01% |
+76
| New | +$289K |
|
2102
Kadant
KAI
$3.69B
| $268K | ﹤0.01% |
5,687
-14,393
| -72% | -$717K |
|
2103
Alamo Group
ALG
$2.01B
| $266K | ﹤0.01% |
4,870
+62
| +1% | +$3.56K |
|
2104
REX American Resources
REX
$1.46B
| $265K | ﹤0.01% |
24,984
-666
| -3% | -$7.02K |
|
2105
StoneX
SNEX
$8.83B
| $265K | ﹤0.01% |
40,363
+15
| +0% | +$101 |
|
|
EVRI
2106
DELISTED
Everi Holdings
EVRI
| $264K | ﹤0.01% |
34,124
+143
| +0.4% | +$1.12K |
|
2107
Columbus McKinnon
CMCO
$465M
| $260K | ﹤0.01% |
10,408
+52
| +0.5% | +$1.29K |
|
2108
First Interstate BancSystem
FIBK
$3.7B
| $259K | ﹤0.01% |
9,330
-87
| -0.9% | -$2.41K |
|
2109
Argan
AGX
$7.98B
| $258K | ﹤0.01% |
6,390
-74,737
| -92% | -$2.68M |
|
2110
MiMedx Group
MDXG
$626M
| $252K | ﹤0.01% |
21,778
-1,076
| -5% | -$11.1K |
|
2111
Great Southern Bancorp
GSBC
$863M
| $251K | ﹤0.01% |
5,945
-11
| -0.2% | -$439 |
|
2112
Ennis
EBF
$546M
| $249K | ﹤0.01% |
13,386
+39
| +0.3% | +$630 |
|
|
HA
2113
DELISTED
Hawaiian Holdings, Inc.
HA
| $249K | ﹤0.01% |
+10,478
| New | +$245K |
|
2114
Ubiquiti
UI
$31.8B
| $248K | ﹤0.01% |
7,765
-978
| -11% | -$30.1K |
|
2115
Strategic Education
STRA
$1.71B
| $245K | ﹤0.01% |
5,691
-23,903
| -81% | -$1.17M |
|
|
NATI
2116
DELISTED
National Instruments Corp
NATI
| $244K | ﹤0.01% |
+8,298
| New | +$255K |
|
2117
Myers Industries
MYE
$1.18B
| $241K | ﹤0.01% |
12,681
-224
| -2% | -$3.95K |
|
2118
Petrobras
PBR
$121B
| $240K | ﹤0.01% |
26,564
-11,178
| -30% | -$100K |
|
|
GSIG
2119
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $239K | ﹤0.01% |
15,881
+97
| +0.6% | +$1.4K |
|
|
FPO
2120
DELISTED
First Potomac Realty Trust
FPO
| $238K | ﹤0.01% |
23,084
-6,809
| -23% | -$73.4K |
|
2121
ePlus
PLUS
$2.33B
| $237K | ﹤0.01% |
12,356
+84
| +0.7% | +$1.75K |
|
|
FPT
2122
DELISTED
Federated Premier Intermediate M
FPT
| $236K | ﹤0.01% |
17,912
-175
| -1% | -$2.22K |
|
2123
Westwood Holdings Group
WHG
$182M
| $234K | ﹤0.01% |
3,935
+101
| +3% | +$5.97K |
|
2124
iShares MSCI United Kingdom ETF
EWU
$4.04B
| $232K | ﹤0.01% |
6,365
| – | – |
|
|
SBY
2125
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $232K | ﹤0.01% |
14,220
-4,639
| -25% | -$72.8K |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.